148 related articles for article (PubMed ID: 29218110)
1. Downregulation of cathepsin G reduces the activation of CD4+ T cells in murine autoimmune diabetes.
Zou F; Lai X; Li J; Lei S; Hu L
Am J Transl Res; 2017; 9(11):5127-5137. PubMed ID: 29218110
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D supplementation induces CatG-mediated CD4
Lai X; Liu X; Cai X; Zou F
Am J Physiol Endocrinol Metab; 2022 Jan; 322(1):E74-E84. PubMed ID: 34779254
[TBL] [Abstract][Full Text] [Related]
3. In vitro xenorecognition of adult pig pancreatic islet cells by splenocytes from nonobese diabetic or non-diabetes-prone mice.
Rivereau AS; You S; Lalain S; Gouin E; Saï P
Transplantation; 1998 Sep; 66(5):633-8. PubMed ID: 9753345
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with a co-expression DNA plasmid containing GAD65 fragment gene and IL-10 gene induces regulatory CD4(+) T cells that prevent experimental autoimmune diabetes.
Liu X; Zhang S; Li X; Zheng P; Hu F; Zhou Z
Diabetes Metab Res Rev; 2016 Sep; 32(6):522-33. PubMed ID: 26797873
[TBL] [Abstract][Full Text] [Related]
5. Molecular role of TGF-beta, secreted from a new type of CD4+ suppressor T cell, NY4.2, in the prevention of autoimmune IDDM in NOD mice.
Han HS; Jun HS; Utsugi T; Yoon JW
J Autoimmun; 1997 Jun; 10(3):299-307. PubMed ID: 9218758
[TBL] [Abstract][Full Text] [Related]
6. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.
Chosich N; Harrison LC
Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738
[TBL] [Abstract][Full Text] [Related]
7. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.
Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A
Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970
[TBL] [Abstract][Full Text] [Related]
8. Regulation of cathepsin G reduces the activation of proinsulin-reactive T cells from type 1 diabetes patients.
Zou F; Schäfer N; Palesch D; Brücken R; Beck A; Sienczyk M; Kalbacher H; Sun Z; Boehm BO; Burster T
PLoS One; 2011; 6(8):e22815. PubMed ID: 21850236
[TBL] [Abstract][Full Text] [Related]
9. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice.
Han HS; Jun HS; Utsugi T; Yoon JW
J Autoimmun; 1996 Jun; 9(3):331-9. PubMed ID: 8816968
[TBL] [Abstract][Full Text] [Related]
10. A crucial role of CD4 T cells as a functional source of CD154 in the initiation of insulin-dependent diabetes mellitus in the non-obese diabetic mouse.
Eshima K; Mora C; Wong FS; Green EA; Grewal IS; Flavell RA
Int Immunol; 2003 Mar; 15(3):351-7. PubMed ID: 12618479
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection.
Guo Z; Wu T; Kirchhof N; Mital D; Williams JW; Azuma M; Sutherland DE; Hering BJ
Transplantation; 2001 Jun; 71(11):1656-65. PubMed ID: 11435979
[TBL] [Abstract][Full Text] [Related]
12. Presentation of beta-cell antigens to CD4+ and CD8+ T cells of non-obese diabetic mice.
Shimizu J; Kanagawa O; Unanue ER
J Immunol; 1993 Aug; 151(3):1723-30. PubMed ID: 8101546
[TBL] [Abstract][Full Text] [Related]
13. Impaired activation of islet-reactive CD4 T cells in pancreatic lymph nodes of B cell-deficient nonobese diabetic mice.
Greeley SA; Moore DJ; Noorchashm H; Noto LE; Rostami SY; Schlachterman A; Song HK; Koeberlein B; Barker CF; Naji A
J Immunol; 2001 Oct; 167(8):4351-7. PubMed ID: 11591759
[TBL] [Abstract][Full Text] [Related]
14. Role of CD4+CD45RA+ T cells in the development of autoimmune diabetes in the non-obese diabetic (NOD) mouse.
Sempé P; Ezine S; Marvel J; Bédossa P; Richard MF; Bach JF; Boitard C
Int Immunol; 1993 May; 5(5):479-89. PubMed ID: 8318452
[TBL] [Abstract][Full Text] [Related]
15. Ethylenecarbodiimide-fixed splenocytes carrying whole islet antigens decrease the incidence of diabetes in NOD mice via down-regulation of effector memory T cells and autoantibodies.
Zou J; Gao X; Liu T; Liang R; Liu Y; Wang G; Wang L; Liu N; Sun P; Wang Z; Wang S; Shen Z
Endocr J; 2018 Sep; 65(9):943-952. PubMed ID: 29998909
[TBL] [Abstract][Full Text] [Related]
16. MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo.
Kupfer TM; Crawford ML; Pham K; Gill RG
J Immunol; 2005 Aug; 175(4):2309-16. PubMed ID: 16081800
[TBL] [Abstract][Full Text] [Related]
17. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.
Mellanby RJ; Thomas D; Phillips JM; Cooke A
Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252
[TBL] [Abstract][Full Text] [Related]
18. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
Goldrath AW; Barber L; Chen KE; Alters SE
J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149
[TBL] [Abstract][Full Text] [Related]
19. Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.
Makhlouf L; Grey ST; Dong V; Csizmadia E; Arvelo MB; Auchincloss H; Ferran C; Sayegh MH
Transplantation; 2004 Apr; 77(7):990-7. PubMed ID: 15087759
[TBL] [Abstract][Full Text] [Related]
20. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
